Literature DB >> 8624089

Atrophy of the hippocampal formation in early familial Alzheimer's disease. A longitudinal MRI study of at-risk members of a family with an amyloid precursor protein 717Val-Gly mutation.

N C Fox1, E K Warrington, J M Stevens, M N Rossor.   

Abstract

The hippocampal formation (HF) is known from pathological and magnetic resonance imaging (MRI) studies to become severely atrophied in established Alzheimer's disease (AD). This study examined whether changes in the HF could also be detected in very early AD by scanning subjects at risk of developing familial AD (FAD). Five at risk members of a pedigree with the amyloid precursor protein (APP) 717 valine to glycine mutation underwent serial MRI scanning with volumetric measurement of the HF as well as neurological and neuropsychological assessments. Over a period of two years two subjects became clinically affected, a loss of up to 20% of the volume of the HF occurred in the two years over which symptoms first appeared. Asymmetrical HF atrophy was shown to have been present before the development of overt symptoms. This may have important implications for early diagnosis in AD more generally.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8624089     DOI: 10.1111/j.1749-6632.1996.tb34423.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  25 in total

1.  In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI.

Authors:  John Pluta; Paul Yushkevich; Sandhitsu Das; David Wolk
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

2.  Measuring longitudinal change in the hippocampal formation from in vivo high-resolution T2-weighted MRI.

Authors:  Sandhitsu R Das; Brian B Avants; John Pluta; Hongzhi Wang; Jung W Suh; Michael W Weiner; Susanne G Mueller; Paul A Yushkevich
Journal:  Neuroimage       Date:  2012-01-28       Impact factor: 6.556

Review 3.  Bridging animal and human models of exercise-induced brain plasticity.

Authors:  Michelle W Voss; Carmen Vivar; Arthur F Kramer; Henriette van Praag
Journal:  Trends Cogn Sci       Date:  2013-09-09       Impact factor: 20.229

4.  Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.

Authors:  J M Schott; C Frost; J L Whitwell; D G Macmanus; R G Boyes; M N Rossor; N C Fox
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

5.  Problems associated with biological markers of Alzheimer's disease.

Authors:  H J Frey; K M Mattila; M A Korolainen; T Pirttilä
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

Review 6.  Structural imaging in early pre-states of dementia.

Authors:  Charles D Smith
Journal:  Biochim Biophys Acta       Date:  2011-07-14

Review 7.  Olfactory dysfunction: its early temporal relationship and neural correlates in the pathogenesis of Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  J Neural Transm (Vienna)       Date:  2015-05-06       Impact factor: 3.575

8.  Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.

Authors:  Winnie S Liang; Travis Dunckley; Thomas G Beach; Andrew Grover; Diego Mastroeni; Douglas G Walker; Richard J Caselli; Walter A Kukull; Daniel McKeel; John C Morris; Christine Hulette; Donald Schmechel; Gene E Alexander; Eric M Reiman; Joseph Rogers; Dietrich A Stephan
Journal:  Physiol Genomics       Date:  2006-10-31       Impact factor: 3.107

9.  Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia.

Authors:  Yuan-Yu Hsu; Norbert Schuff; An-Tao Du; Kevin Mark; Xiaoping Zhu; Dawn Hardin; Michael W Weiner
Journal:  J Magn Reson Imaging       Date:  2002-09       Impact factor: 4.813

10.  Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia.

Authors:  C DeCarli; D Mungas; D Harvey; B Reed; M Weiner; H Chui; W Jagust
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.